Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Apremilast did not work for treating severe alopecia areata.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Low vitamin D levels are common in people with Alopecia Areata.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.

Zidovudine may cause hair loss in advanced-stage HIV patients.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The conclusion suggests that treatments targeting root causes of chronic diseases may be developed by focusing on gene expression and lifestyle factors.

A woman with lupus had rare severe symptoms but improved with treatment.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

The 3D-SeboSkin model effectively simulates Hidradenitis suppurativa and is useful for future research.

Dermal Papilla Cells grown in 3D and with stem cells better mimic natural hair growth conditions than cells grown in 2D.